Skip to content

bibag

by Fresenius Medical Care Renal Therapies Group, LLC

510(k) K162716

bibag is a medical device (FDA Class II; FDA product code KPO, Dialysate Concentrate For Hemodialysis (Liquid Or Powder)) made by Fresenius Medical Care Renal Therapies Group, LLC, cleared under FDA 510(k) K162716 on 18 May 2017, active as of 10 Oct 2026. One FDA recall is linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 10 Oct 2026.

Regulatory status

as of registry sync 10 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK162716 Date18 May 2017ClearedStatusActive

Official records

From the FDA record

Received by the FDA
29 Sep 2016
FDA decision
18 May 2017 (Substantially Equivalent)
FDA review time
231 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K162716 (openFDA), as read on 10 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

1 recall · FDA

    • Terminated Z-2082-2021 FDA Class II initiated 28 Apr 2021

    Exposed to freezing temperatures due to refrigerated truck malfunctions

Timeline

2 dated events

  1. Cleared FDA 510(k) K162716
  2. Recall initiated FDA recalls Z-2082-2021

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
KPO
Device class
Class II
Regulation
21 CFR Part 876.5820
Advisory committee
Gastroenterology, Urology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)).

Other devices from Fresenius Medical Care Renal Therapies Group, LLC

See all devices from Fresenius Medical Care Renal Therapies Group, LLC →